**** SECTION 2 - COMPOSITION, INFORMATION ON INGREDIENTS ****
+----------------+--------------------------------------+----------+-----------+
| CAS# | Chemical Name | % | EINECS# |
|----------------|--------------------------------------|----------|-----------|
|----------------|--------------------------------------|----------|-----------|
| 7782-61-8 |Iron(III) nitrate nonahydrate | +98 | unlisted |
|----------------|--------------------------------------|----------|-----------|
+----------------+--------------------------------------+----------+-----------+
Text for R-phrases: see Section 16
Hazard Symbols: XI O
Risk Phrases: 36/37/38 8
**** SECTION 3 - HAZARDS IDENTIFICATION ****
EMERGENCY OVERVIEW
Irritating to eyes, respiratory system and skin. Contact with
combustible material may cause fire.Hygroscopic (absorbs moisture
from the air).
Potential Health Effects
Eye:
May cause eye irritation.
Skin:
May cause skin irritation.
Ingestion:
May cause gastrointestinal irritation with nausea, vomiting and
diarrhea. May cause methemoglobinemia, cyanosis (bluish
discoloration of skin due to deficient oxygenation of the blood),
convulsions, and death.
Inhalation:
May cause respiratory tract irritation. May cause methemoglobinemia,
cyanosis (bluish discoloration of skin due to deficient oxygenation
of the blood), convulsions, tachycardia, dyspnea (labored breathing),
and death. Methemoglobinemia is characterized by dizziness,
drowsiness, headache, shortness of breath, cyanosis (bluish
discoloration of skin due to deficient oxygenation of the blood),
rapid heart rate and chocolate-brown blood.
Chronic:
May cause methemoglobinemia, which is characterized by
chocolate-brown colored blood, headache, weakness, dizziness, breath
shortness, cyanosis (bluish skin due to deficient oxygenation of
blood), rapid heart rate, unconsciousness and possible death.
**** SECTION 4 - FIRST AID MEASURES ****
Eyes:
Flush eyes with plenty of water for at least 15 minutes,
occasionally lifting the upper and lower eyelids. Get medical aid
immediately.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15
minutes while removing contaminated clothing and shoes. Wash clothing
before reuse.
Ingestion:
If victim is conscious and alert, give 2-4 cupfuls of milk or water.
Never give anything by mouth to an unconscious person. Get medical
aid immediately.
Inhalation:
Remove from exposure and move to fresh air immediately. If not
breathing, give artificial respiration. If breathing is difficult,
give oxygen. Get medical aid.
Notes to Physician:
Antidote:
The use of Deferoxamine as a chelating agent should be determined
only by qualified medical personnel.
**** SECTION 5 - FIRE FIGHTING MEASURES ****
General Information:
As in any fire, wear a self-contained breathing apparatus in
pressure-demand, MSHA/NIOSH (approved or equivalent), and full
protective gear. Strong oxidizer. Contact with combustible materials
may cause a fire. Use water spray to keep fire-exposed containers
cool. Use water with caution and in flooding amounts.
Extinguishing Media:
Use water only! Contact professional fire-fighters immediately. Do
NOT use dry chemicals, CO2, Halon or foams.
**** SECTION 6 - ACCIDENTAL RELEASE MEASURES ****
General Information: Use proper personal protective equipment as indicated
in Section 8.
Spills/Leaks:
Clean up spills immediately, observing precautions in the Protective
Equipment section. Remove all sources of ignition. Provide
ventilation. In case of spill, sweep up solid or absorb liquid with
inert material, then place into a biohazard container. Wear
protective equipment.
**** SECTION 7 - HANDLING and STORAGE ****
Handling:
Wash thoroughly after handling. Remove contaminated clothing and
wash before reuse. Use only in a well-ventilated area. Minimize dust
generation and accumulation. Avoid contact with eyes, skin, and
clothing. Avoid contact with clothing and other combustible
materials. Avoid ingestion and inhalation.
Storage:
Keep away from heat, sparks, and flame. Do not store near
combustible materials. Store in a tightly closed container. Store in
a cool, dry, well-ventilated area away from incompatible substances.
**** SECTION 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION ****
Engineering Controls:
Use adequate ventilation to keep airborne concentrations low.
Personal Protective Equipment
Eyes:
Wear appropriate protective eyeglasses or chemical
safety goggles as described by OSHA's eye and face
protection regulations in 29 CFR 1910.133 or European
Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin
exposure.
Clothing:
Wear appropriate protective clothing to prevent skin
exposure.
Respirators:
Follow the OSHA respirator regulations found in 29
CFR 1910.134 or European Standard EN 149. Always use
a NIOSH or European Standard EN 149 approved
respirator when necessary.
**** SECTION 9 - PHYSICAL AND CHEMICAL PROPERTIES ****
Physical State: Crystals (moist)
Color: off-white or light purple
Odor: None reported.
pH: Not available.
Vapor Pressure: Negligible.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: 47.2 deg C
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water: Soluble.
Specific Gravity/Density:
Molecular Formula: FeN3O9.9H2O
Molecular Weight: 404.00
**** SECTION 10 - STABILITY AND REACTIVITY ****
Chemical Stability:
Stable. However, may decompose if heated. Stable. May discolor on
exposure to light.
Conditions to Avoid:
Incompatible materials, light, ignition sources, dust generation,
combustible materials.
Incompatibilities with Other Materials:
Strong oxidizing agents.
Hazardous Decomposition Products:
Nitrogen oxides.
Hazardous Polymerization: Has not been reported.
**** SECTION 11 - TOXICOLOGICAL INFORMATION ****
RTECS#:
CAS# 7782-61-8: NO7175000
CAS# 10421-48-4: QU8915000
LD50/LC50:
CAS# 7782-61-8: Oral, rat: LD50 = 3250 mg/kg.
CAS# 10421-48-4.
Carcinogenicity:
Iron(III) nitrate nonahydrate -
Not listed by ACGIH, IARC, NIOSH, NTP, or OSHA.
Ferric nitrate anhydrous -
Not listed by ACGIH, IARC, NIOSH, NTP, or OSHA.
See actual entry in RTECS for complete information.
**** SECTION 12 - ECOLOGICAL INFORMATION ****
**** SECTION 13 - DISPOSAL CONSIDERATIONS ****
Dispose of in a manner consistent with federal, state, and local regulations.
**** SECTION 14 - TRANSPORT INFORMATION ****
IATA
Shipping Name: FERRIC NITRATE
Hazard Class: 5.1
UN Number: 1466
Packing Group: III
IMO
Shipping Name: FERRIC NITRATE
Hazard Class: 5.1
UN Number: 1466
Packing Group: III
RID/ADR
Shipping Name: FERRIC NITRATE
Hazard Class: 5.1
UN Number: 1466
Packing group: III
**** SECTION 15 - REGULATORY INFORMATION ****
European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: XI O
Risk Phrases:
R 36/37/38 Irritating to eyes, respiratory system
and skin.
R 8 Contact with combustible material may cause
fire.
Safety Phrases:
S 17 Keep away from combustible material.
S 24/25 Avoid contact with skin and eyes.
WGK (Water Danger/Protection)
CAS# 7782-61-8: 1
CAS# 10421-48-4: 1
United Kingdom Occupational Exposure Limits
United Kingdom Maximum Exposure Limits
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 7782-61-8 is not listed on Canada's Ingredient Disclosure List.
CAS# 10421-48-4 is not listed on Canada's Ingredient Disclosure List.
Exposure Limits
CAS# 7782-61-8: OEL-DENMARK:TWA 1 mg(Fe)/m3 JANUARY 1993
OEL-FINLAND:TWA 1 mg(Fe)/m3 JANUARY 1993
OEL-THE NETHERLANDS:TWA 1 mg(Fe)/m3 JANUARY 1993
OEL-SWITZERLAND:TWA 1 mg(Fe)/m3 JANUARY 1993
OEL-UNITED KINGDOM:TWA 1 mg(Fe)/m3;STEL 2 mg(Fe)/m3 JANUARY 1993
CAS# 10421-48-4: OEL-DENMARK:TWA 1 mg(Fe)/m3 JANUARY 1993
OEL-FINLAND:TWA 1 mg(Fe)/m3 JANUARY 1993
OEL-THE NETHERLANDS:TWA 1 mg(Fe)/m3 JANUARY 1993
OEL-SWITZERLAND:TWA 1 mg(Fe)/m3 JANUARY 1993
OEL-UNITED KINGDOM:TWA 1 mg(Fe)/m3;STEL 2 mg(Fe)/m3 JANUARY 1993
OEL IN BULGARIA, COLOMBIA, JORDAN, KOREA check ACGIH TLV
OEL IN NEW ZEALAND, SINGAPORE, VIETNAM check ACGI TLV
US FEDERAL
TSCA
CAS# 7782-61-8 is not on the TSCA Inventory because it is a hydrate.
It is considered to be listed if the CAS number for the anhydrous form
is on the inventory (40CFR720.3(u)(2)).
CAS# 10421-48-4 is not listed on the TSCA inventory.
It is for research and development use only.
**** SECTION 16 - ADDITIONAL INFORMATION ****
MSDS Creation Date: 5/15/1998 Revision #3 Date: 4/16/2004
The information above is believed to be accurate and represents the best
information currently available to us. However, we make no warranty of
merchantability or any other warranty, express or implied, with respect to
such information, and we assume no liability resulting from its use. Users
should make their own investigations to determine the suitability of the
information for their particular purposes. In no way shall the company be
liable for any claims, losses, or damages of any third party or for lost
profits or any special, indirect, incidental, consequential or exemplary
damages, howsoever arising, even if the company has been advised of
the possibility of such damages.
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
|
|
|
| ALL MSDS PAGES IN THIS GROUP
| | NAME | CAS |
|
Creatinine, 99+%
| 60-27-5 |
|
Cholic acid sodium salt, 99% (Titr.)
| 361-09-1 |
|
2,2-Dichlorooctanoic Acid, 95%
| 102272-30-0 |
|
5-Methoxy-2-Nitrobenzoic Acid, 97%
| 1882-69-5 |
|
Ethyl Phenoxyacetate, 98%
| 2555-49-9 |
|
1-Naphthyl Butyrate, 98%
| 3121-70-8 |
|
2,5-Dimethyl-3,4-Diphenylcyclopentadienone Dimer, 97%
| 38883-84-0 |
|
2,6-Dichlorophenyl Isocyanate, 98%
| 39920-37-1 |
|
Ethyl Acetate, 99.5+%, Spectrophotometric Grade
| 141-78-6 |
|
Ethyl acetoacetate, p.a.
| 141-97-9 |
|
Ethylbenzene, 99%
| 100-41-4 |
|
Tetraethyl Orthosilicate
| 78-10-4 |
|
Sodium bisulfite, reagent ACS
| 7446-09-5 |
|
4'-Phenoxyacetophenone, 98%
| 5031-78-7 |
|
3-Amino-2-Methylbenzoic Acid, 97%
| 52130-17-3 |
|
1,2-Dibromoethane, p.a.
| 106-93-4 |
|
Benzyl Sulfide, 98%
| 538-74-9 |
|
2-Amino-4,5-Dimethoxybenzoic Acid, 98%
| 5653-40-7 |
|
2-Carboxycinnamic Acid, 98%
| 612-40-8 |
|
Benzyl sulphone, 98%
| 620-32-6 |
|
1-Naphthol-4-sulfonic acid sodium salt (pract)
| 6099-57-6 |
|
(2S)-Bornane-10,2-Sultam, 99+%, (99+% e.e.)
| 108448-77-7 |
|
1,2-Dichloroethane, spectrophotometric grade, 99+%
| 107-06-2 |
|
Holmium atomic absorption standard solution, 1 mg/ml Ho in 2% HNO3
| 7440-60-0 |
|
Ethylene glycol dimethyl ether, 99+%
| 110-71-4 |
|
Ethyl 2-cyano-3-methyl-2-butenoate, 98%
| 759-58-0 |
|
Ethylenediamine, p.a.
| 107-15-3 |
|
Octanesulfonyl Chloride, 98%
| 7795-95-1 |
|
Iodine Monobromide, 98%
| 7789-33-5 |
|
Ammonium Iron(III)-Citrate
| 1185-57-5 |
|
3-Methyl-2,4-pentanedione, 96%
| 815-57-6 |
|
Iron (III) Chloride, Anhydrous, Reagent (Powder), 96% (Titr.)
| 7705-08-0 |
|
1-Propylpyridinium bromide, 98%
| 873-71-2 |
|
2',5'-Dihydroxypropiophenone, 98%
| 938-46-5 |
|
Ammonium iron(III) oxalate trihydrate, 98%
| 13268-42-3 |
|
3-Bromocyclohexene, 95%
| 1521-51-3 |
|
2,4-Dibromo-2,4-Dimethyl-3-Pentanone, 98%
| 17346-16-6 |
|
1,2-Epoxy-7-octene, 97%
| 19600-63-6 |
|
Allyl Chloroacetate, 98%
| 2916-14-5 |
|
1-Allylimidazole, 97%
| 31410-01-2 |
|
2,4,6-Trichlorobenzoyl chloride, 98%
| 4136-95-2 |
|
Iron(III) chloride hexahydrate, pure, granulated, 99%
| 7705-08-0 |
|
Benzylurea, 98%
| 538-32-9 |
|
Benzyl Acetoacetate, 98%
| 5396-89-4 |
|
4-Amino-3-nitrophenol, 98%
| 610-81-1 |
|
Iron(III) nitrate nonahydrate, reagent ACS
| 7782-61-8 |
|
1-Aminopyridinium iodide, 98%
| 6295-87-0 |
|
Iron(II) chloride tetrahydrate, 99+%
| 13478-10-9 |
|
2,4-Dibromomesitylene, 98%
| 6942-99-0 |
|
5-Amino-2-chlorobenzoic acid, 97%
| 89-54-3 |
|
|